biomass production (ribosome biogenesis, translation)
Lipid biosynthesis
Shift in glucose metabolism AWAY from oxidative phosphorylation (to maximize ATP production) and towards glycolysis
AMP-activated protein kinase (AMPK) is made up of 3 subunits:
a - the catalytic subunit (gets phosphorylated)
B - regulatory subunit
y - regulatory subunit that binds to and senses AMP and ATP
The y subunit of AMPK has 4 major sites
site 1 has a high affinity to ATP
Site 2 usually has nothing
site 3 has high affinity to ATP, ADP, and AMP
site 4 has high affinity with ADP and AMP
depending on what type of energy variation we have (ATP, ADP, AMP) will determine what will bind to the site 3 competitive binding site.
when energy is high (high ATP) ATP binds to site 3
when energy is low (low ATP) AMP/ADP will bind to site 3
this will recruit LKB1 and CaMKKB to phosphorylate the a-subunit changing AMPK conformation
This turns on the AMPK kinase domain
AMPK under different conditions:
under condition of energy sufficiency
Very low levels of AMP and high levels of ATP, so only ATP binds to AMPK
ATP-bound AMPK is a very good substrate for a phosphatase that de-phosphorylates AMPK
Non-phosphorylated AMPK is INACTIVE
AMPK under different conditions:
Under conditions of energy deficiency/stress
Elevated levels of ADP and/or AMP, AMPK binds preferentially to AMP/ADP at site 3
High ADP levels are converted ATP and AMP by adenylyl kinase, to increase ATP levels
AMP-bound AMPK is not a good substrate for the phosphatase, retaining higher AMPK phosphorylation levels
Phosphorylated AMPK is ACTIVE
AMPK function during metabolic stress
AMPK function during metabolic stress
once active, AMPJ action has 2 major outcomes:
REDUCE (inhibit) ATP consumption
INCREASE catabolism (energy production)
Adenylate kinase (AK) can turn ADP into ATP + AMP and vise versa
As ATP levels are starting to decline, ADP concentration will be higher
We can turn ADP into ATP and AMP --> This will increase ATP levels while decreasing ADP
Quick way to get ATP under ADP-rich conditions
AMP will also help to stimulate AMPK
AMPK function during metabolic stress
AMPK controls many cellular processes.
Acetyl CoA carboxylase to control fatty acid metabolism
Glucose uptake into cells
cell migration
AMPK favours catabolism and shuts off ATP consumption: Acetyl-CoA carboxylase (ACC) is inhibited in the process
the phosphorylation of ACC by AMPK inactivates it
Acetyl-CoA carboxylase (ACC)
ACC with ATP makes Malonyl CoA
Malonyl CoA promotes fatty acid synthesis and inhibits B-oxidation
B-oxidation is a mechanism that makes Acetyl CoA
Acetyl CoA: cofactor used in many biological processes where it can be used for energy production
when AMPK phosphorylates ACC this enhances B-oxidation --> Acetyl CoA is made --> more energy
AMPK controls membrane traffic to increase glucose transport into cells:
Glucose transport into cells occurs by the action of GLUT --> a family of glucose transporters at the cell surface
AMPK activation REDUCES the endocytosis of GLUT1 (every cell) and GLUT4 (muscle cells)
More glucose transport proteins at the cell surface = more glucose transport into cells = more ATP production
GLUT is found on the surface of the cell
normally takes in glucose in the cell to make ATP
GLUT normally has a set lifetime before they are sequestered in and recycled --> this controls blood glucose levels
internalized periodically so they are not always on the surface
In a low ATP situation, --> GLUT endocytosis is inhibited
a-arrestins help sequester glucose --> When AMPK is activated it can phosphorylate a-arrestins which inactivates it --> This allows for more glucose transport since GLUT stays on the surface
AMPK slows down cell migration:
Integrin proteins that link the cell to the extracellular matrix are moved around the cell by endocytosis
Cell migration requires the membrane traffic of integrins from the cell posterior to the cell anterior
AMPK activation causes a reduction in the rate of integrin membrane traffic and cell migration
Trafficking of integrins from one face of a cell to another by endocytosis uses up energy --> when AMPK is turned ON it reduces the uptake and endocytosis of integrins --> therefore saving energy
AMPK: is a possible therapeutic target for diabetes treatment
Diabetes: a defect in insulin production (type 1) or insulin action (type 2) that results in elevated blood glucose
AMPK: can increase glucose consumption and metabolism by skeletal muscle cells
Diabetes increases glucose levels which is bad but AMPK increases the consumption of glucose which evens it out
AMPK and cancer
when AMPK is ON
Pro-tumor: can generate ATP to help cancer survival
Anti-tumor: Can halt cancer growth by arresting cell cycle
when AMPK is OFF
Pro-tumor: Can generate biomass to help cancer cells grow
Anti-tumor: Prevents metabolic adaptation in cancer
Oxygen levels are also important for metabolism
Aerobic respiration is required for glycolysis
We need a sensor system to monitor oxygen levels in cells
This is important so that cellular metabolism can switch if oxygen levels are too low
Hypoxia-inducible factor 1a (HIF1a) helps yo check for O2 levels
when there is high O2 levels, there will be low HIF1a levels (OFF)
When there is low O2 levels, there will be high HIF1a levels. (ON)
cells switch to anaerobic respiration and secrete VEGF (growth factor) that stimulates angiogenesis
goes back to high O2 levels --> low HIF1a --> no more VEGF
The mechanism for HIF1a (normoxia level) (high O2)
HIF1a gets some PTM form HPH
the proline residue gets hydroxylated
the lysine residue gets acetylated
This PTM allows the attachment of ubiquitin protein ligase complex
ubiquitination of HIF1a leads to degradation by proteasome.
in hypoxia conditions (lots of HIF1a, little O2):
HIF1a is phosphorylated by ARNT
These 2 act together as a transcription factor that responds to HIF1a response elements (HRE)
DNA is regulated this way
can have positive/negative functions
Hypoxia conditions of HIF1a:
can increase blood flow and ATP production (increase of GLUT1 and glycolytic enzymes) allowing for improved cell survival in times where O2 is scarce
under normal O2 (normoxia) levels, HIF1 is hydroxylated and acetylated, resulting in ubiquitination of HIF1 by ubiquitin protein ligase complex and degraded by proteosomes.
under conditions of reduced (O2) (hypoxia) levels, HIF1 is stabilized and phosphorylated by ARNT --> they become transcription factors to improve cell survival
When present, HIF1 binds to the promoter region of target genes, leading to increased expression of:
vascular endothelial growth factor (VEGF) to promote angiogenesis
Inducible nitric oxide synthase (iNOS): vasodilation to increase blood flow
GLUT glucose transporters and glycolytic enzymes to make more ATP
Reactive oxygen species (ROS) --> biproduct of enzymatic function by NADPH oxidase and electron transport chain (ETC) of the mitochondria during ATP production.
ROS is bad --> will damage protein, DNA, lipids
we have mechanisms that turn ROS into something that isn't as bad
ROS can contribute to cell signalling (E.g. phosphatases are inactivated by ROS)
AND/OR
ROS can lead to protein/DNA/lipid damage.
Sensing of reactive oxygen species by p38 MAPK (non-classical
Ask1 senses for High levels of ROS
Ask1 is a mitogen-activated protein kinase kinase kinase (MAP3K)
Ask1 phosphorylates and activates MKK3/4/6, which in turn phosphorylates and activated p38 (MAPK)
NADPH oxidase -> mitochondrial enzyme that is part of the ETC that catalyzes oxygen into super oxide free radicals
highly reactive form of oxygen that interacts with proteins,DNA,etc in a damaging manner.